Yu et al., 2013 - Google Patents
Neutralization of HIV by milk expressed antibodyYu et al., 2013
View PDF- Document ID
- 17958342791997030437
- Author
- Yu X
- Pollock D
- Duval M
- Lewis C
- Joseph K
- Meade H
- Cavacini L
- Publication year
- Publication venue
- JAIDS Journal of Acquired Immune Deficiency Syndromes
External Links
Snippet
Background: In some areas of the world, mother-to-child transmission of HIV remains a significant problem in part due to widespread breastfeeding, which is essential because of scarce supply of a safe replacement, protection conferred by breast milk against many …
- 102000004965 antibodies 0 title abstract description 70
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
- C07K16/1036—Retroviridae, e.g. leukemia viruses
- C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2812—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD4
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse Transcribing RNA Viruses
- C12N2740/00011—Reverse Transcribing RNA Viruses
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ferrantelli et al. | Post-exposure prophylaxis with human monoclonal antibodies prevented SHIV89. 6P infection or disease in neonatal macaques | |
| Haigwood et al. | Passive immunotherapy in simian immunodeficiency virus-infected macaques accelerates the development of neutralizing antibodies | |
| Gorny et al. | Identification of a new quaternary neutralizing epitope on human immunodeficiency virus type 1 virus particles | |
| Leroux-Roels et al. | Randomized phase I: safety, immunogenicity and mucosal antiviral activity in young healthy women vaccinated with HIV-1 Gp41 P1 peptide on virosomes | |
| Su et al. | Which antibody functions are important for an HIV vaccine? | |
| Florese et al. | Evaluation of passively transferred, nonneutralizing antibody-dependent cellular cytotoxicity-mediating IgG in protection of neonatal rhesus macaques against oral SIVmac251 challenge | |
| Shen et al. | GP41-specific antibody blocks cell-free HIV type 1 transcytosis through human rectal mucosa and model colonic epithelium | |
| Hessell et al. | Animal models in HIV-1 protection and therapy | |
| Veillette et al. | Role of HIV-1 envelope glycoproteins conformation and accessory proteins on ADCC responses | |
| Braibant et al. | The role of neutralizing antibodies in prevention of HIV-1 infection: what can we learn from the mother-to-child transmission context? | |
| Lee et al. | Anti-HIV-1 antibody-dependent cellular cytotoxicity: is there more to antibodies than neutralization? | |
| Barbian et al. | Neutralization properties of simian immunodeficiency viruses infecting chimpanzees and gorillas | |
| Ding et al. | Employing broadly neutralizing antibodies as a human immunodeficiency virus prophylactic & therapeutic application | |
| Rosenberg et al. | Protection of newborn macaques by plant-derived HIV broadly neutralizing antibodies: a model for passive immunotherapy during breastfeeding | |
| Grunst et al. | Antibody-dependent cellular cytotoxicity, infected cell binding and neutralization by antibodies to the SIV envelope glycoprotein | |
| Grunst et al. | Potent antibody-dependent cellular cytotoxicity of a V2-specific antibody is not sufficient for protection of macaques against SIV challenge | |
| Mao et al. | CD8+ and CD20+ lymphocytes cooperate to control acute simian immunodeficiency virus/human immunodeficiency virus chimeric virus infections in rhesus monkeys: modulation by major histocompatibility complex genotype | |
| Wen et al. | GPI-anchored single chain Fv-an effective way to capture transiently-exposed neutralization epitopes on HIV-1 envelope spike | |
| Yu et al. | Neutralization of HIV by milk expressed antibody | |
| Stamos et al. | Effect of Passive Administration of Monoclonal Antibodies Recognizing Simian Immunodeficiency Virus (SIV) V2 in CH59-Like Coil/Helical or β-Sheet Conformations on Time of SIVmac251 Acquisition | |
| Sato et al. | Antibody-mediated neutralization and simian immunodeficiency virus models of HIV/AIDS | |
| Murakami et al. | A novel mother-to-child human T-cell leukaemia virus type 1 (HTLV-1) transmission model for investigating the role of maternal anti-HTLV-1 antibodies using orally infected mother rats | |
| Falkensammer et al. | Role of complement and antibodies in controlling infection with pathogenic simian immunodeficiency virus (SIV) in macaques vaccinated with replication-deficient viral vectors | |
| Gros et al. | Efficient mother-to-child transfer of antiretroviral immunity in the context of preclinical monoclonal antibody-based immunotherapy | |
| Ghulam-Smith | Two sides to the same antibody: assessing the role of neutralizing and non-neutralizing antibodies in mother-to-child transmission of HIV-1 |